APHINITY Archives - Medical Conferences

Positive effects of adding pertuzumab to trastuzumab + chemotherapy in operable HER2 breast cancer

Trial

APHINITY

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 23:13

Presented By

Dr Ian E. Krop, Dana-Farber Cancer Institute, USA

Trial

Phase 3, APHINITY

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 14:00

Presented By

Prof. Sharon Giordano, MD Anderson, Houston, USA

Trial

APHINITY, KATHERINE, ExteNET

Conference

BCC 2019

Type

Peer-reviewed article

21 May 2019 23:44

Trial

APHINITY

Conference

BCC 2019

Type

Peer-reviewed article

21 May 2019 13:35

Presented By

Prof. Eric Winer, Dana-Farber Cancer Institute, Boston, USA

Trial

NSABP B-18, NSABP B-27, ACOSOG Z1071, NEO-ALTTO, APHINITY, I-SPY2

Conference

BCC 2019

Type

Peer-reviewed article

21 May 2019 09:49